<|ref|>title<|/ref|><|det|>[[81, 51, 422, 71]]<|/det|>
# CORPORATE GOVERNANCE

<|ref|>table_caption<|/ref|><|det|>[[81, 142, 242, 152]]<|/det|>
Attendance at Meetings

<|ref|>table<|/ref|><|det|>[[85, 157, 912, 382]]<|/det|>

<table><tr><td>Directors</td><td>Status</td><td>Board</td><td>AC</td><td>RPT</td><td>RC</td><td>NGC</td></tr><tr><td>Mr. Dilhan C. Fernando</td><td>ED</td><td>4/4</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Mr. Himendra S. Ranaweera</td><td>ED</td><td>4/4</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Mr. Malik J. Fernando</td><td>ED</td><td>4/4</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Mr. Roshan C. Tissaaratchy</td><td>ED</td><td>1/4</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Mr. Darshana Gunasekera</td><td>ED</td><td>4/4</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Ms. Minette D. A. Perera</td><td>NED</td><td>4/4</td><td>4/4</td><td>4/4</td><td>2/2</td><td>2/2</td></tr><tr><td>Mr. Rajan N. Asirwatham</td><td>NED</td><td>4/4</td><td>3/4</td><td>3/4</td><td>2/2</td><td>1/2</td></tr><tr><td>Dr. Ravindra A. Fernando</td><td>NEID</td><td>4/4</td><td>4/4</td><td>4/4</td><td>2/2</td><td>2/2</td></tr><tr><td>Mr. John M. Lo</td><td>NEID/ SID</td><td>4/4</td><td>3/4</td><td>4/4</td><td>-</td><td>2/2</td></tr><tr><td>Mr. Anil L. N. Dias<br>(appointed w.e.f. 01.01.2025)</td><td>NEID</td><td>1/1</td><td>1/1</td><td>-</td><td>-</td><td>-</td></tr></table>

<|ref|>table<|/ref|><|det|>[[85, 405, 912, 644]]<|/det|>

<table><tr><td>Quarter 01</td><td>Quarter 02</td><td>Quarter 03</td><td>Quarter 04</td></tr><tr><td>·Review and approval of<br>Quarterly financials</td><td>·Review and approval of<br>Quarterly financials</td><td>·Review and approval of<br>Quarterly financials</td><td>·Welcome of Mr. Anil<br>Dias to the Board as<br>an Independent Non-<br>Executive Director</td></tr><tr><td>·Review and approval of<br>OPEX and CAPEX budgets<br>for the F/Y 2024/25</td><td>·Pre-concurrence of<br>International Ethics<br>Standards Board for<br>Accountants (IESBA)<br>·Approval of final dividends<br>for 2023/24</td><td>·Approval of Policies per<br>CSE guidelines<br>·Appointment of the Risk<br>Management Committee<br>·Appointment of the ESG<br>Committee<br>·Review on investment<br>in new tea bagging<br>machines</td><td>·Review and approval of<br>Quarterly and YTD<br>·Business plan and<br>strategies for the next year<br>financial year</td></tr></table>

<|ref|>title<|/ref|><|det|>[[83, 668, 511, 681]]<|/det|>
# GRI 2-18 BOARD AND BOARD SUB-COMMITTEE EVALUATION

<|ref|>text<|/ref|><|det|>[[81, 686, 871, 727]]<|/det|>
The effectiveness of the Board and its Subcommittees is assessed annually through a comprehensive evaluation process. This includes a mandatory self-assessment completed by all Directors, who provide valuable feedback on the Board's composition,dynamics, and overall performance to ensure continuous improvement in governance and decision-making.

<|ref|>title<|/ref|><|det|>[[81, 745, 407, 755]]<|/det|>
# EVALUATING THE PERFORMANCE OF THE CEO

<|ref|>text<|/ref|><|det|>[[81, 761, 904, 802]]<|/det|>
The performance of the Executive Chairman/CEO is evaluated annually by the Nomination and Governance Committee at the conclusion of each financial year. This assessment is benchmarked against the Company's strategic goals, operational targets, and key performance indicators established at the start of the year.

<|ref|>text<|/ref|><|det|>[[81, 821, 914, 861]]<|/det|>
Following the evaluation, the Board submits its recommendations to the Human Resources and Remuneration Committee, which considers any adjustments to the Executive Chairman/CEO compensation, ensuring alignment with performance outcomes, long-term value creation, and shareholder expectations.